OR7E24 and neoplasm: Aberrations and subsequent abnormal expression of OR7E24 have been observed in glioblastoma, hepatocellular carcinoma, and stomach cancer [15, 77], with an association with microsatellite instability and high tumor mutational burden in the latter.